What is hepatitis?
Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents.1Each strain of the virus can cause liver disease, making an accurate diagnosis critical for disease mitigation and improving patient outcomes.
What is the healthcare burden of hepatitis?
Viral hepatitis is a worldwide public health issue that impacts millions of people. The WHO estimates that 296 million people worldwide are living with hepatitis B, 58 million people worldwide are living with hepatitis C, and 1.5 million people were newly infected with chronic hepatitis B along with1.5 million people were newly infected with chronic hepatitis C.2
The role of diagnostics is key as hepatitis infections can be “silent” making many infected individuals unaware of their diagnosis. Although hepatitis is widespread and highly prevalent, many people worldwide live with hepatitis B or C and do not have accessibility to testing or adequate treatment.1
Due to the high prevalence of hepatitis, World Hepatitis Day is recognized annually on July 28th – on the birthday of Dr. Baruch Blumberg who discovered hepatitis B in 1967, and proceeded to develop the first hepatitis B vaccine.3World Hepatitis Day promotes the need to raise awareness, education, and encourage actions to prevent these infections to support better public health globally.
Hepatitis – Our Diagnostic Offer
A Complete Panel to Address a Complex Clinical Picture
Hepatitis, especially hepatitis B, presents a complex clinical picture. Various markers are necessary for accurate diagnosis and efficient monitoring.
The VIDAS® Hepatitis panel includes 11 automated assays offering a complete solution for the diagnosis and monitoring of Hepatitis A, B, C and E. Used together, they enable clinicians to provide a differential diagnosis for patients presenting with symptoms suggestive of hepatitis.
-
PREVI® COLOR GRAM
A Market-Leading Automated Gram Stainer Offering Confidence in Results
Gram staining is a key step in your microbiology workflow, and PREVI® COLOR GRAM is the system to streamline it and provide timely staining results for impactful decisions.
-
RAL® STAINER
Secures Your AFB Staining and Eases Slide Reading
Easier and faster reading and no daily maintenance with RAL® STAINER. This closed fully automated bath system offers a unique fixative solution that prevents any cross-contamination.
-
RAPIDEC® CARBA NP
Rapid, Reliable Test for Carbapenemase-Producing Bacteria
This test gives reliable results in under 2 hours, making it the quick and easy way to control carbapenemase producers and meet diagnostic and screening challenges, improve patient management, and control healthcare associated infections. -
SARS-COV-2 FLUA/FLUB/RSV R-GENE®
Real-time PCR detection kit
Detect & differentiate SARS-CoV-2, Influenza A, Influenza B and RSV in 1 PCR test.
-
STOOL PREPROCESSING DEVICE
Stool preprocessing for molecular testing
Stool preprocessing device enabling standardized stool sample preparation for nucleic acid extraction of viruses, bacteria and parasites in about 5 minutes.
-
TTV R-GENE®
Guiding Transplant Risk Management
Real-time PCR assay for Torque Teno Virus detection and quantification to support transplant management.
-
VIDAS® 3
Trusted. Robust. Innovative.
With its advanced immunoassay technology and optimized testing protocols, the fully automated VIDAS® 3 benchtop immunoanalyzer empowers your lab with confidence, offering the precise results you need, when you need them.
-
VIDAS® Arboviruses Panel
Suspecting an Arbovirus? Think Dengue and Chikungunya
Our VIDAS® offer of immunoassays directed against arboviruses diseases improve access to medically important automated diagnostic tests.
-
VIDAS® BONE & MINERAL METABOLISM
VIDAS® BONE & MINERAL METABOLISM is a complete solution for the diagnosis of chronic kidney diseases, the determination of vitamin D, and iron deficiency.
-
VIDAS® C. difficile Panel
Rapid identification of C. difficile infection
The VIDAS® C. difficile GDH and TOXIN A & B (CDAB) are two complementary tests used as an aid in the diagnosis of C. difficile associated disease. NEW IVDR: VIDAS® GDH and VIDAS® CDAB are already CE Marked under the new In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR).
-
VIDAS® Cardiac Biomarkers
Improve Patient Outcomes and Optimize Patient Management in the Emergency Department
An easy access to innovative tests for acute and complex situations to deliver reliable, fast, and actionable results to clinicians. bioMérieux with VIDAS® is providing a comprehensive emergency & critical care offer for better patient management in the emergency department.
-
VIDAS® D-DIMER EXCLUSION™ II
Safe Exclusion of Venous Thromboembolism
VIDAS® D-Dimer Exclusion™ II is a highly-sensitive automated D-Dimer assay. Used in conjunction with assessment of clinical pretest probability, it allows safe exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE) in both low and intermediate suspected outpatient risk groups in just 20 minutes.
-
-
VIDAS® High sensitive Troponin I
Optimize the Management of Acute Coronary Syndrome (ACS)
The VIDAS® High sensitive Troponin I assay is intended to be used as an aid in the diagnosis of myocardial infarction delivering a diagnosis in only two hours and for the risk stratification of patients with acute coronary syndrome.
-
VIDAS® Hormone & Fertility Assays
A Full Panel for the Diagnosis and Monitoring of Infertility and Adrenocortical Disorders
The VIDAS® Fertility panel provides key diagnostic tools for the investigation of reproductive hormone dysfunctions such as precocious and delayed puberty, amenorrhea, hirsutism, hyperprolactinemia, perimenopause and menopause, hypogonadism, gynecomastia, and azoospermia
Product availability varies by country. Consult your local bioMérieux representative for availability in your country.
Useful Resources on Hepatitis
Contact Us for Information on Our Solutions for Viral Hepatitis
References
1. World Health Organization. (2022). Hepatitis. Www.who.int.https://www.who.int/health-topics/hepatitis#tab=tab_1
2. WHO. (2021). Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Www.who.int. https://www.who.int/publications/i/item/9789240027077
3. World Hepatitis Day — July 28th | CDC. (2020, July 31). Www.cdc.gov. https://www.cdc.gov/hepatitis/awareness/worldhepday.htm
